Dr. Pavan Kumar Bapatla's Profile
M.Sc, Ph.D (Biotechnology)
Dr. Pavan Kumar Bapatla holds a Ph.D. in Biotechnology from Madurai Kamaraj University, with postdoctoral research at the Volcani Center in Israel, He specializes in epi-genetics and molecular biology. He has keen interest in genomic technologies and how it can be applied for liquid view more..
Written / Edited / Medically Reviewed
Cell-Free DNA Biomarkers in Neurodegenerative Disorders
Explore the role of cell-free DNA biomarkers in differentiating Parkinson’s disease and multiple system atrophy (MSA).
PeCan-Seq: Revolutionizing ctDNA Analysis for Childhood Cancers
PeCan-Seq enables sensitive, non-invasive ctDNA analysis for pediatric cancers, with high accuracy for hematologic malignancies and some solid tumors.
AI-Driven Liquid Biopsy Enhances Early Detection of Ovarian Cancer
A breakthrough AI-powered liquid biopsy combining cell-free DNA and protein biomarkers improves early detection of ovarian cancer, aiding in accurate screening.
Natera Vs. NeoGenomics: A Legal Battle Shaping the Future of Genetic Testing
Why are Natera and NeoGenomics battling in court over DNA technology? Discover how this legal fight could change the future of genetic testing.
Role of Cell-Free DNA in Fetal Aneuploidy Detection
Cell-free DNA (cfDNA) is a non-invasive method for detecting fetal aneuploidies, such as Down syndrome, during pregnancy.